Welcome to Dwaey, specifically on Roxatidine page.
This medicine contains important and useful components, as it consists of
Roxatidine is available in the market in concentration.
Roxatidine
Before starting treatment with roxatidine, it is essential for patients to consult with their healthcare provider to ensure the drug is safe and suitable for their specific health needs. The following precautions should be considered:
- Liver disease: Roxatidine is metabolized by the liver, and patients with liver dysfunction may experience a slower metabolism of the drug, leading to higher levels in the bloodstream. Those with severe liver disease should avoid this medication or use it with caution, under careful supervision.
- Renal impairment: Patients with kidney problems, particularly those with moderate to severe renal impairment, should use roxatidine cautiously. Reduced kidney function may increase the risk of adverse effects due to the accumulation of the drug. Dosage adjustments may be necessary.
- Elderly patients: Older adults are more likely to experience side effects from roxatidine, such as dizziness or confusion, particularly if they have other underlying health conditions like kidney or liver problems. Lower doses may be appropriate for elderly patients.
- Pregnancy and breastfeeding: There is limited information regarding the safety of roxatidine during pregnancy and breastfeeding. It should only be used during pregnancy if the benefits outweigh the potential risks. Breastfeeding mothers should consult their healthcare provider before taking this medication.
- Prolonged use: Long-term use of roxatidine, especially for more than 2 weeks, should be monitored by a healthcare provider, as it may mask underlying gastrointestinal conditions like peptic ulcers or cancer.
Patients should seek medical advice prior to starting treatment to avoid unnecessary risks associated with roxatidine.
Roxatidine is an H2 receptor antagonist used primarily to reduce stomach acid production. It is prescribed for:
- Gastroesophageal reflux disease (GERD): Roxatidine is effective in treating GERD, a condition where stomach acid frequently leaks into the esophagus, causing symptoms such as heartburn and regurgitation.
- Peptic ulcers: Roxatidine is used to treat both gastric and duodenal ulcers. It works by reducing gastric acid secretion, promoting ulcer healing and alleviating associated pain.
- Zollinger-Ellison syndrome: A rare condition characterized by excessive acid production in the stomach, often due to tumors in the pancreas or duodenum. Roxatidine helps reduce this excess acid.
- Prevention of stress ulcers: In patients at risk of stress ulcers (for example, those undergoing major surgery or in critical care), roxatidine is used to reduce acid secretion and prevent ulcer formation.
Roxatidine helps control the symptoms of acid-related gastrointestinal disorders and promotes healing of ulcers.
Roxatidine should be avoided in the following conditions:
- Hypersensitivity: If a patient is allergic to roxatidine or any other component of the formulation, they should not use this medication.
- Severe liver impairment: Roxatidine is metabolized by the liver, and its use is contraindicated in patients with severe liver dysfunction, as the drug may accumulate in the body and cause toxicity.
- Severe renal impairment: In patients with severe renal impairment, the use of roxatidine may lead to increased drug concentrations in the blood, raising the risk of side effects.
- Pregnancy and breastfeeding: Roxatidine should not be used during pregnancy unless absolutely necessary and prescribed by a healthcare provider. Its safety during breastfeeding has not been well established, so it is generally not recommended during lactation.
It is important to inform the healthcare provider of any medical conditions before starting treatment to avoid contraindications.
While roxatidine is generally well-tolerated, it can cause side effects in some individuals. These can range from mild to severe and include:
- Common side effects:
- Headache: One of the most frequently reported side effects.
- Dizziness: Some patients may experience dizziness or lightheadedness, particularly when standing up quickly.
- Fatigue: Tiredness or weakness is a possible side effect, although it is typically mild.
- Gastrointestinal issues: Nausea, constipation, or diarrhea can occur but are usually mild.
- Severe side effects:
- Liver dysfunction: In rare cases, roxatidine may cause liver problems, such as jaundice or elevated liver enzymes. If these symptoms occur, the medication should be discontinued immediately.
- Allergic reactions: Rash, itching, swelling (especially of the face, lips, or throat), and difficulty breathing could indicate an allergic reaction, requiring urgent medical attention.
- Confusion or hallucinations: Particularly in elderly patients, roxatidine may cause mental confusion or hallucinations in some cases, especially when used in high doses.
- Severe dizziness or fainting: These symptoms could indicate low blood pressure, especially in individuals with preexisting heart conditions.
Patients should report any unusual or severe symptoms to their healthcare provider immediately.
Roxatidine works by blocking the H2 (histamine-2) receptors in the stomach lining. These receptors are responsible for stimulating the production of gastric acid when activated by histamine. By inhibiting H2 receptors, roxatidine reduces the secretion of stomach acid, which:
- Promotes ulcer healing: Less acid in the stomach allows existing ulcers (gastric and duodenal) to heal and reduces symptoms like pain.
- Reduces GERD symptoms: By decreasing stomach acid production, roxatidine helps alleviate the symptoms of acid reflux, such as heartburn and regurgitation.
- Prevents stress ulcers: By lowering acid levels, it prevents damage to the stomach lining in critically ill patients who are at risk for stress-related ulcers.
In summary, roxatidine exerts its therapeutic effects by reducing gastric acid production, providing relief from acid-related gastrointestinal conditions.
Roxatidine can interact with other medications, affecting its efficacy or causing unwanted side effects:
- Antacids: The use of antacids in combination with roxatidine may reduce the drug's absorption and effectiveness. Antacids should be taken at least 1-2 hours apart from roxatidine to avoid interaction.
- Warfarin: Roxatidine can enhance the effects of warfarin, an anticoagulant, increasing the risk of bleeding. Monitoring of blood clotting parameters (INR) is recommended for patients taking both drugs.
- Other H2 blockers: Combining roxatidine with other H2 blockers (e.g., ranitidine, famotidine) is not recommended as it could lead to an increased risk of side effects or an excessive reduction in stomach acid.
- Ketoconazole: The absorption of ketoconazole, an antifungal drug, may be reduced when taken with roxatidine, as stomach acidity is decreased. Alternative antifungal treatments may be needed for patients on roxatidine.
- Phenytoin: Roxatidine may increase the plasma concentration of phenytoin, an anticonvulsant, leading to a risk of toxicity. Monitoring is advised if these medications are taken together.
Patients should inform their healthcare provider of all medications they are taking to avoid harmful interactions.
The typical dosing regimen for roxatidine in adults depends on the condition being treated:
- For gastroesophageal reflux disease (GERD): The usual starting dose is 75 mg to 150 mg once daily, typically taken before bedtime. This dose may be adjusted based on the severity of the condition.
- For peptic ulcers:
- Gastric ulcer: The typical dose is 150 mg once daily at bedtime for 4-8 weeks.
- Duodenal ulcer: Similar to gastric ulcer dosing, with a typical dose of 150 mg once daily before bedtime.
- For Zollinger-Ellison syndrome: Higher doses may be required, typically starting with 300 mg once daily, adjusted as needed based on clinical response.
Dosage should be adjusted based on the severity of the condition and the patient’s response to treatment.
Roxatidine is not typically prescribed to children under the age of 12 unless specifically directed by a healthcare provider. The safety and efficacy of roxatidine in pediatric populations have not been well established.
- For children older than 12 years: The usual dose for peptic ulcers and GERD is 75 mg to 150 mg once daily, administered before bedtime.
Since roxatidine is not commonly used in pediatric patients, the dose should be individualized and prescribed with caution.
Always consult a healthcare provider before starting roxatidine or any new medication, particularly in special populations like children, pregnant women, or those with existing health conditions.
Patients with renal impairment should receive careful consideration and may require dose adjustments:
- Mild to moderate renal impairment (creatinine clearance >30 mL/min): No significant adjustment is needed.
- Severe renal impairment (creatinine clearance <30 mL/min): Dose reduction or careful monitoring is recommended, as the drug may accumulate in the bloodstream, increasing the risk of side effects.
Renal function should be monitored in patients with known kidney problems, and dose adjustments should be made accordingly.
Not available in a medicine form yet